Overview Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection Status: Terminated Trial end date: 2021-05-19 Target enrollment: Participant gender: Summary Evelo will investigate the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection Phase: Phase 2 Details Lead Sponsor: Evelo Biosciences, Inc.